Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi
about
Protein conjugates of synthetic saccharides elicit higher levels of serum IgG lipopolysaccharide antibodies in mice than do those of the O-specific polysaccharide from Shigella dysenteriae type 1Synthesis and immunogenicity evaluation of Salmonella enterica serovar Paratyphi A O-specific polysaccharide conjugated to diphtheria toxoid.Physical and chemical characterization and immunologic properties of Salmonella enterica serovar typhi capsular polysaccharide-diphtheria toxoid conjugatesTreatment with succinic anhydride improves the immunogenicity of Shigella flexneri type 2a O-specific polysaccharide-protein conjugates in miceSyntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice.Phase 1 and phase 2 studies of Salmonella enterica serovar paratyphi A O-specific polysaccharide-tetanus toxoid conjugates in adults, teenagers, and 2- to 4-year-old children in Vietnam.Vi-CRM 197 as a new conjugate vaccine against Salmonella Typhi.Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to Pseudomonas aeruginosa recombinant exoprotein ALaboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.Synthesis and some immunologic properties of an O-acetyl pectin [poly(1-->4)-alpha-D-GalpA]-protein conjugate as a vaccine for typhoid fever.Evaluation of the immunogenicity and biological activity of the Citrobacter freundii Vi-CRM197 conjugate as a vaccine for Salmonella enterica serovar TyphiLocal and systemic antibody responses to dextran-cholera toxin B subunit conjugatesCharacterization of a human monoclonal immunoglobulin M (IgM) antibody (IgMBEN) specific for Vi capsular polysaccharide of Salmonella typhiSynthesis, characterization, and immunological properties in mice of conjugates composed of detoxified lipopolysaccharide of Salmonella paratyphi A bound to tetanus toxoid with emphasis on the role of O acetylsSynthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linkerComparison of conjugates composed of lipopolysaccharide from Shigella flexneri type 2a detoxified by two methods and bound to tetanus toxoid.A Study on Longevity of Immune Response after Vaccination with Salmonella Typhi Vi Conjugate Vaccine (Pedatyph™) in ChildrenPreparation and characterization of group A meningococcal capsular polysaccharide conjugates and evaluation of their immunogenicity in mice.Vaccination against typhoid fever: present statusSynthesis, characterization, and some immunological properties of conjugates composed of the detoxified lipopolysaccharide of Vibrio cholerae O1 serotype Inaba bound to cholera toxin.Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionateSerum antibody response in adult volunteers elicited by injection of Streptococcus pneumoniae type 12F polysaccharide alone or conjugated to diphtheria toxoidRelation between structure and immunologic properties of the Vi capsular polysaccharide.Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi.Synthesis of the Heptasaccharide Repeating Unit of the Cell Wall O-Polysaccharide of Enterotoxigenic Escherichia coli O139.The influence of conjugation variables on the design and immunogenicity of a glycoconjugate vaccine against Salmonella Typhi.Design and production of conjugate vaccines against S. Paratyphi A using an O-linked glycosylation system in vivo.An Unmutated IgM Response to the Vi Polysaccharide of Salmonella Typhi Contributes to Protective Immunity in a Murine Model of Typhoid.
P2860
Q28343287-A8CBE030-9CD9-4B7E-8723-D409E70180FAQ33577920-8CA8D03D-3184-4B0E-8A63-6CDB3801B880Q33613531-C4F1AC04-1FB0-43C1-AA3F-4FA66AB0E9EDQ34002272-8AE8FD60-7F39-4B6C-96A4-436F95919879Q34002606-4632EDF9-5C91-4549-8C0A-BECCD12D3D2CQ34003647-2E131866-9C3D-48CD-8697-C1901EFD4468Q34179527-FF61EB48-D4CD-4351-A76C-35A4D6779F3DQ34526987-1C81E304-C020-4EF5-8981-E026D22B8262Q34541176-93D276E7-7423-4D7C-BDBF-EE7933A63F38Q34548668-0C45A4D5-ECFC-4ED7-BF80-2E798E3F40A4Q34739155-2925FDC0-3224-4876-803F-6918C13C04ADQ35413377-BC5AC581-4E39-411C-A640-6DCE71964A54Q35450564-1950EC08-0D83-4CF6-869A-FB00BF86DC48Q35505761-4E7D797B-60FD-4EFF-887F-9B628E566641Q35548581-2BC7F319-2318-4874-B8F0-0344606E612DQ35771562-A6D0FD36-E67D-4A1A-9D79-671F3D145934Q35792498-450F3914-6290-4231-9FEE-D0FDBE8FDAD9Q35801994-96E72DD8-313E-4934-B6C5-E908BABAFFB8Q36794750-19473941-C7AE-432D-8A96-1681994C5726Q36949262-FD9D44D2-7A84-4320-BCEA-50BC7219AF0AQ36958120-511F4B8B-E8A9-4355-9389-EC729A1D734BQ36985836-A9AA4A2E-7992-4CAA-8C73-6892583531CCQ36990350-ECF7641C-326D-4645-9C09-70D0155ED594Q38298541-4CA78429-8AE1-4C28-B563-25C8E0F1A643Q40291567-14A1BC2E-A95A-48F6-9E8B-EBF7B5531421Q42173577-4A1EE32C-72A7-4A8D-A93F-A2869D6EB208Q47245287-90A0964C-9FFE-42D5-89DA-68DF5AC49AA6Q48505004-71C7B402-A1C3-45D4-953F-7B637C3E141EQ54216843-5DD7730D-53E9-46D3-98B2-6E5377B64E6B
P2860
Comparative immunogenicities of Vi polysaccharide-protein conjugates composed of cholera toxin or its B subunit as a carrier bound to high- or lower-molecular-weight Vi
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1989
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparative immunogenicities o ...... - or lower-molecular-weight Vi
@en
Comparative immunogenicities o ...... or lower-molecular-weight Vi.
@nl
type
label
Comparative immunogenicities o ...... - or lower-molecular-weight Vi
@en
Comparative immunogenicities o ...... or lower-molecular-weight Vi.
@nl
prefLabel
Comparative immunogenicities o ...... - or lower-molecular-weight Vi
@en
Comparative immunogenicities o ...... or lower-molecular-weight Vi.
@nl
P2093
P2860
P1476
Comparative immunogenicities o ...... - or lower-molecular-weight Vi
@en
P2093
P2860
P304
P407
P577
1989-12-01T00:00:00Z